Sort
21,453 grants matching “tuberculosis”
STRUCTURE BASED ANALOGS AS ANTIOPPORTUNISTIC AGENTS
$246,872Duquesne University · R01 · FY2000 · AI
Core--Training
$246,830Maureen Sanderson · University Of Texas Hlth Sci Ctr Houston · P20 · FY2007 · MD
Enhancing TB vaccine with gene silencing
$246,750Jinhee Lee · Univ Of Massachusetts Med Sch Worcester · R21 · FY2013 · AI
A Study of Heterologous Immunity Induced by Neonatal BCG Vaccination
$246,750Daniel H. Libraty · Univ Of Massachusetts Med Sch Worcester · R21 · FY2011 · AI
Developing TB Cell Wall Enzyme Drug Targets
$246,703Colorado State University-Fort Collins · P01 · FY2005 · AI
Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
$246,592John Lucian Davis · Yale University · R01 · FY2025 · HL
Identification and characterization of non-coding RNAs in diverse bacteria
$246,510Jonathan Livny · Broad Institute, Inc. · R00 · FY2010 · AI
Stress-potentiated screening to identify novel inhibitors of M. tuberculosis
$246,418Robert N Husson · Boston Children'S Hospital · R21 · FY2012 · AI
Tuberculosis Control & Elimination
$246,291Glenn Wasserman · Hawaii State Department Of Health · U52 · FY2016 · PS
Administrative Core
$246,286Kenneth D Stuart · Seattle Biomedical Research Institute · U19 · FY2015 · AI
Functions and mechanisms of M. tuberculosis S/T kinases
$246,262Thomas C Alber · University Of California Berkeley · R01 · FY2007 · GM
MBRS RISE Program at California State University, Fresno
$246,262Alejandro Calderon-Urrea · California State University Fresno · R25 · FY2008 · GM
Immune Activation and Isoniazid Metabolism in HIV/TB
$246,256Gregory P. Bisson · University Of Pennsylvania · R21 · FY2013 · AI
Vanderbilt Infection Pathogenesis and Epidemiology Research Training Program
$246,254Spyros A Kalams · Vanderbilt University · T32 · FY2013 · AI
Functions and mechanisms of M. tuberculosis S/T kinases
$246,249Thomas C Alber · University Of California Berkeley · R01 · FY2008 · GM
An imaging approach to understanding the impact of heterogeneity in microenvironments and lesion properties during Mycobacterium tuberculosis infection
$246,200Shumin Tan · Tufts University Boston · R21 · FY2019 · AI
Ubiquitin-like Proteins and Proteasomes of Archaea
$246,138Julie A Maupin-Furlow · University Of Florida · R01 · FY2017 · GM
High content, high throughput, diversity screen for novel anti-tubercular agents targeting intracellular bacteria
$246,125Tanya Parish · Seattle Children'S Hospital · R21 · FY2023 · AI
HIV, AIDS and Opportunistic Infections
$246,075Vinayaka R Prasad · Albert Einstein College Of Medicine · T32 · FY2014 · AI
Pseudopteroxazole and Related Antitubercular Agents
$246,060Michael Harmata · University Of Missouri-Columbia · R01 · FY2006 · AI
Role of Lung Repair and Regeneration Pathways in Tuberculosis
$246,000Mushtaq Ahmed · University Of Chicago · R21 · FY2024 · AI
Acquired susceptibility to pulmonary TB
$246,000Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R21 · FY2009 · AI
Direct ligand-based control of C. albicans zinc cluster transcription factors
$246,000Lawrence Christopher Myers · Dartmouth College · R21 · FY2019 · AI
MACROPHAGE IRON METABOLISM AND TUBERCULOSIS INFECTION
$246,000Megan B Murray · Harvard School Of Public Health · R21 · FY2006 · AI
Comprehensive characterization of Rv0678 bedaquiline resistance-conferring polymorphisms
$246,000John Zapata Metcalfe · University Of California, San Francisco · R21 · FY2025 · AI